7 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... #Algorithm #Anticoagulation ... #Management #Hematology ... #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... incidental DVT or PE in cancer ... thrombosis in cancer ... #Management #Hematology ... #Oncology
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS
Venous Thrombosis - Arterial Thrombosis
INR Target
Duration
Recurrence

Dr. Laurent ARNAUD
Antiphospholipid Syndrome ... #APS #management ... #EULAR2019 #guidelines ... #rheumatology #hematology ... #treatment
Portal Vein Thrombosis (PVT) Treatment Algorithm
 - If concern for ischemic: anti-coag+multidisciplinary care
 - W/o cirrhosis+recent
(PVT) Treatment ... Algorithm - If ... concern for ischemic ... #management #Algorithm ... #hepatology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
can result in thrombosis ... #management #algorithm ... #pharmacology #treatment ... #decisionaid #cardiology ... #hematology #warfarin
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
syndrome - ... Thrombophilia • Cancer ... anticoagulation #duration #management ... #DVT #hematology ... #length #treatment
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
Myelodysplastic syndromes ... current treatment ... algorithm 2018. ... Network (NCCN) guidelines ... #algorithm #hematology